Devex features GHTC paper on COVID-19 impacts to R&D
Devex cited a report released by GHTC assessing the impact of the COVID-19 pandemic on global health R&D.
ViewDevex cited a report released by GHTC assessing the impact of the COVID-19 pandemic on global health R&D.
ViewHealth Europa covered a report released by GHTC assessing the impact of the COVID-19 pandemic on global health R&D.
ViewScienceBoard.net, a publication covering life science and pharmaceutical trends, reported on a findings from GHTC's report, Pain Points and Potential: How COVID-19 is Reshaping Global Health R&D.
ViewThe Global Health NOW newsletter included a feature on GHTC's paper examining how the COVID-19 pandemic is weakening some areas of global health R&D, while opening new opportunities in others.
ViewHomeland Preparedness News featured coverage of GHTC's 2020 Innovating for Impact Awards, which honored the CARB-X partnership for antibiotic research.
ViewGHTC Director Jamie Bay Nishi was quoted in an article in the August Bulletin of the World Health Organization (WHO) on accelerating regulatory processes for COVID-19 technologies.
PDFA commentary piece authored by GHTC Director Jamie Bay Nishi on the importance of funding USAID to fight disparities in COVID-19 innovation was published by Global Citizen.
ViewA letter endorsed by GHTC's director Jamie Bay Nishi calling for greater investment in research on COVID-19 diagnostics through the ACT Accelerator was featured in Politico Europe's Morning Health Care newsletter.
Learn moreIn an article about the introduction of new legislation to improve global health security, Security Magazine mentioned GHTC's endorsement of the legislation.
ViewIn an article about the introduction of the Global Health Security and Diplomacy Act, Homeland Preparedness News cited GHTC's endorsement of the bill.
View